The current valuation score of Revolution Medicines Inc is 8.99, ranking 68 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -25.62, which is -78.05% below the recent high of -5.62 and 0.00% above the recent low of -25.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.